 | CJ8 | Name: | (2~{R},3~{R})-2,3-bis(oxidanyl)-~{N},~{N}'-dipropyl-butanediamide | Formula: | C10 H20 N2 O4 | SMILES: | CCCNC(=O)[CH](O)[CH](O)C(=O)NCCC | InChi: | InChI=1S/C10H20N2O4/c1-3-5-11-9(15)7(13)8(14)10(16)12-6-4-2/h7-8,13-14H,3-6H2,1-2H3,(H,11,15)(H,12,16)/t7-,8-/m1/s1 | Definition date: | 2017-11-28 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | (2~{R},3~{R})-2,3-bis(oxidanyl)-~{N},~{N}'-dipropyl-butanediamide |
|
 | CJE | Name: | ethyl (2~{R})-2-methyl-3-oxidanylidene-butanoate | Formula: | C7 H12 O3 | SMILES: | CCOC(=O)[CH](C)C(C)=O | InChi: | InChI=1S/C7H12O3/c1-4-10-7(9)5(2)6(3)8/h5H,4H2,1-3H3/t5-/m1/s1 | Definition date: | 2017-11-28 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | ethyl (2~{R})-2-methyl-3-oxidanylidene-butanoate |
|
 | 8TU | Name: | (6R,8S,9S)-8-(hydroxymethyl)-6,11,11-tris(oxidanyl)-9-propyl-dodecanoic acid | Formula: | C16 H32 O6 | SMILES: | CCC[CH](CC(C)(O)O)[CH](CO)C[CH](O)CCCCC(O)=O | InChi: | InChI=1S/C16H32O6/c1-3-6-12(10-16(2,21)22)13(11-17)9-14(18)7-4-5-8-15(19)20/h12-14,17-18,21-22H,3-11H2,1-2H3,(H,19,20)/t12-,13+,14+/m0/s1 | Definition date: | 2017-09-20 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | (6~{R},8~{S},9~{S})-8-(hydroxymethyl)-6,11,11-tris(oxidanyl)-9-propyl-dodecanoic acid |
|
 | E01 | Name: | (1r,1'S,3'S,5'S,7'S)-spiro[cyclohexane-1,2'-tricyclo[3.3.1.1~3,7~]decan]-4-amine | Formula: | C15 H25 N | SMILES: | C1(CCC2(CC1)C3CC4CC2CC(C3)C4)N | InChi: | InChI=1S/C15H25N/c16-14-1-3-15(4-2-14)12-6-10-5-11(8-12)9-13(15)7-10/h10-14H,1-9,16H2/t10-,11+,12-,13+,14-,15- | Definition date: | 2017-11-20 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | (1r,1'S,3'S,5'S,7'S)-spiro[cyclohexane-1,2'-tricyclo[3.3.1.1~3,7~]decan]-4-amine |
|
 | F1T | Name: | 3,6-dimethyl-~{N}-[4-(trifluoromethyl)phenyl]-[1,2]oxazolo[5,4-d]pyrimidin-4-amine | Formula: | C14 H11 F3 N4 O | SMILES: | Cc1nc(Nc2ccc(cc2)C(F)(F)F)c3c(C)noc3n1 | InChi: | InChI=1S/C14H11F3N4O/c1-7-11-12(18-8(2)19-13(11)22-21-7)20-10-5-3-9(4-6-10)14(15,16)17/h3-6H,1-2H3,(H,18,19,20) | Definition date: | 2018-05-16 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | 3,6-dimethyl-~{N}-[4-(trifluoromethyl)phenyl]-[1,2]oxazolo[5,4-d]pyrimidin-4-amine |
|
 | F82 | Name: | 2-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-methoxy-phenyl]-~{N}-(1-propan-2-ylpyrazol-4-yl)ethanamide | Formula: | C25 H27 N5 O5 | SMILES: | COc1cc(Oc2ncnc3cc(OC)c(OC)cc23)ccc1CC(=O)Nc4cnn(c4)C(C)C | InChi: | InChI=1S/C25H27N5O5/c1-15(2)30-13-17(12-28-30)29-24(31)8-16-6-7-18(9-21(16)32-3)35-25-19-10-22(33-4)23(34-5)11-20(19)26-14-27-25/h6-7,9-15H,8H2,1-5H3,(H,29,31) | Definition date: | 2018-06-07 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | 2-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-2-methoxy-phenyl]-~{N}-(1-propan-2-ylpyrazol-4-yl)ethanamide |
|
 | F88 | Name: | ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(1-ethylpyrazol-4-yl)ethanamide | Formula: | C23 H23 N5 O4 | SMILES: | CCn1cc(CC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cn1 | InChi: | InChI=1S/C23H23N5O4/c1-4-28-13-15(12-26-28)9-22(29)27-16-5-7-17(8-6-16)32-23-18-10-20(30-2)21(31-3)11-19(18)24-14-25-23/h5-8,10-14H,4,9H2,1-3H3,(H,27,29) | Definition date: | 2018-06-07 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(1-ethylpyrazol-4-yl)ethanamide |
|
 | F8B | Name: | ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(4-propan-2-yl-1,2,3-triazol-1-yl)ethanamide | Formula: | C23 H24 N6 O4 | SMILES: | COc1cc2ncnc(Oc3ccc(NC(=O)Cn4cc(nn4)C(C)C)cc3)c2cc1OC | InChi: | InChI=1S/C23H24N6O4/c1-14(2)19-11-29(28-27-19)12-22(30)26-15-5-7-16(8-6-15)33-23-17-9-20(31-3)21(32-4)10-18(17)24-13-25-23/h5-11,13-14H,12H2,1-4H3,(H,26,30) | Definition date: | 2018-06-07 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(4-propan-2-yl-1,2,3-triazol-1-yl)ethanamide |
|
 | F8H | Name: | ~{N}-[4-[[5-fluoranyl-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-2-(4-propan-2-yl-1,2,3-triazol-1-yl)ethanamide | Formula: | C24 H26 F N7 O3 | SMILES: | COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(nn4)C(C)C)cc3)ncnc2c1 | InChi: | InChI=1S/C24H26FN7O3/c1-15(2)21-12-32(31-30-21)13-22(33)28-16-4-6-17(7-5-16)29-24-23-19(25)10-18(35-9-8-34-3)11-20(23)26-14-27-24/h4-7,10-12,14-15H,8-9,13H2,1-3H3,(H,28,33)(H,26,27,29) | Definition date: | 2018-06-07 | Last modified: | 2018-09-14 | Release date: | 2018-09-19 | Identifier: | ~{N}-[4-[[5-fluoranyl-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-2-(4-propan-2-yl-1,2,3-triazol-1-yl)ethanamide |
|
 | NOS | Name: | INOSINE | Formula: | C10 H12 N4 O5 | SMILES: | OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3C(=O)NC=Nc23 | InChi: | InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2018-09-13 | Identifier: | 9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1~{H}-purin-6-one |
|
 | FYH | Name: | 3-(morpholin-4-ylmethyl)-~{N}-[4-(trifluoromethyloxy)phenyl]benzamide | Formula: | C19 H19 F3 N2 O3 | SMILES: | FC(F)(F)Oc1ccc(NC(=O)c2cccc(CN3CCOCC3)c2)cc1 | InChi: | InChI=1S/C19H19F3N2O3/c20-19(21,22)27-17-6-4-16(5-7-17)23-18(25)15-3-1-2-14(12-15)13-24-8-10-26-11-9-24/h1-7,12H,8-11,13H2,(H,23,25) | Definition date: | 2018-08-17 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | 3-(morpholin-4-ylmethyl)-~{N}-[4-(trifluoromethyloxy)phenyl]benzamide |
|
 | G9K | Name: | [2-(1H-indol-3-yl)-1H-imidazol-4-yl](8-methoxy-1,4-benzodioxin-6-yl)methanone | Formula: | C21 H15 N3 O4 | SMILES: | COc2c1c(OC=CO1)cc(c2)C(c3cnc(n3)c5c4c(cccc4)nc5)=O | InChi: | InChI=1S/C21H15N3O4/c1-26-17-8-12(9-18-20(17)28-7-6-27-18)19(25)16-11-23-21(24-16)14-10-22-15-5-3-2-4-13(14)15/h2-11,22H,1H3,(H,23,24) | Definition date: | 2018-04-27 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | [2-(1H-indol-3-yl)-1H-imidazol-4-yl](8-methoxy-1,4-benzodioxin-6-yl)methanone |
|
 | HRY | Name: | 5-(4-{[(3-chlorophenyl)methyl]amino}-2-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}quinazolin-6-yl)-1-methylpyridin-2(1H)-one | Formula: | C29 H34 Cl N7 O | SMILES: | n3c2ccc(C=1C=CC(=O)N(C=1)C)cc2c(nc3N4CCN(CC4)CCN(C)C)NCc5cc(Cl)ccc5 | InChi: | InChI=1S/C29H34ClN7O/c1-34(2)11-12-36-13-15-37(16-14-36)29-32-26-9-7-22(23-8-10-27(38)35(3)20-23)18-25(26)28(33-29)31-19-21-5-4-6-24(30)17-21/h4-10,17-18,20H,11-16,19H2,1-3H3,(H,31,32,33) | Definition date: | 2018-07-19 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | 5-(4-{[(3-chlorophenyl)methyl]amino}-2-{4-[2-(dimethylamino)ethyl]piperazin-1-yl}quinazolin-6-yl)-1-methylpyridin-2(1H)-one |
|
 | KGN | Name: | D-chiro inositol hexakisphosphate | Formula: | C6 H18 O24 P6 | SMILES: | O[P](O)(=O)O[CH]1[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH]1O[P](O)(O)=O | InChi: | InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/t1-,2-,3-,4-,5+,6+/m0/s1 | Definition date: | 2018-01-30 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | (2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate |
|
 | N7G | Name: | (2R)-2-hydroxy-N-{3-[(5-methoxypentyl)amino]-3-oxopropyl}-3,3-dimethylbutanamide | Formula: | C15 H30 N2 O4 | SMILES: | CC(C)(C)C(O)C(NCCC(NCCCCCOC)=O)=O | InChi: | InChI=1S/C15H30N2O4/c1-15(2,3)13(19)14(20)17-10-8-12(18)16-9-6-5-7-11-21-4/h13,19H,5-11H2,1-4H3,(H,16,18)(H,17,20)/t13-/m0/s1 | Definition date: | 2017-09-06 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | (2R)-2-hydroxy-N-{3-[(5-methoxypentyl)amino]-3-oxopropyl}-3,3-dimethylbutanamide |
|
 | K7V | Name: | neo-Inositol pentakisphosphate | Formula: | C6 H17 O21 P5 | SMILES: | O[CH]1[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH](O[P](O)(O)=O)[CH]1O[P](O)(O)=O | InChi: | InChI=1S/C6H17O21P5/c7-1-2(23-28(8,9)10)4(25-30(14,15)16)6(27-32(20,21)22)5(26-31(17,18)19)3(1)24-29(11,12)13/h1-7H,(H2,8,9,10)(H2,11,12,13)(H2,14,15,16)(H2,17,18,19)(H2,20,21,22)/t1-,2+,3-,4-,5+,6- | Definition date: | 2018-01-31 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | [(1~{S},2~{R},4~{S},5~{R})-3-oxidanyl-2,4,5,6-tetraphosphonooxy-cyclohexyl] dihydrogen phosphate |
|
 | BWA | Name: | N-{4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-N'-[(pyridin-3-yl)methyl]urea | Formula: | C22 H18 N4 O3 | SMILES: | c1(ccc(cc1)CN3C(=O)c2ccccc2C3=O)NC(=O)NCc4cnccc4 | InChi: | InChI=1S/C22H18N4O3/c27-20-18-5-1-2-6-19(18)21(28)26(20)14-15-7-9-17(10-8-15)25-22(29)24-13-16-4-3-11-23-12-16/h1-12H,13-14H2,(H2,24,25,29) | Definition date: | 2017-08-29 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | N-{4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-N'-[(pyridin-3-yl)methyl]urea |
|
 | BWS | Name: | L-gamma-glutamyl-L-alanylglycine | Formula: | C10 H17 N3 O6 | SMILES: | NC(CCC(=O)NC(C(NCC(=O)O)=O)C)C(=O)O | InChi: | InChI=1S/C10H17N3O6/c1-5(9(17)12-4-8(15)16)13-7(14)3-2-6(11)10(18)19/h5-6H,2-4,11H2,1H3,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1 | Definition date: | 2017-08-31 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | L-gamma-glutamyl-L-alanylglycine |
|
 | BXJ | Name: | N-{3-[(2R)-6-{[3-amino-4-(morpholine-4-carbonyl)phenyl]amino}-5-oxo-2,5-dihydropyrazin-2-yl]-2-methylphenyl}-4-(piperidin-1-yl)benzamide | Formula: | C34 H37 N7 O4 | SMILES: | C1(=NC(C=NC1=O)c4c(c(NC(c3ccc(N2CCCCC2)cc3)=O)ccc4)C)Nc6ccc(C(N5CCOCC5)=O)c(c6)N | InChi: | InChI=1S/C34H37N7O4/c1-22-26(6-5-7-29(22)39-32(42)23-8-11-25(12-9-23)40-14-3-2-4-15-40)30-21-36-33(43)31(38-30)37-24-10-13-27(28(35)20-24)34(44)41-16-18-45-19-17-41/h5-13,20-21,30H,2-4,14-19,35H2,1H3,(H,37,38)(H,39,42) | Definition date: | 2017-09-01 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | N-{3-[(2R)-6-{[3-amino-4-(morpholine-4-carbonyl)phenyl]amino}-5-oxo-2,5-dihydropyrazin-2-yl]-2-methylphenyl}-4-(piperidin-1-yl)benzamide |
|
 | BXM | Name: | 4-tert-butyl-N-[2-methyl-3-(1-methyl-5-{[5-(morpholine-4-carbonyl)pyridin-2-yl]amino}-6-oxo-1,6-dihydropyridin-3-yl)phenyl]benzamide | Formula: | C34 H37 N5 O4 | SMILES: | c4(C=3C=C(Nc1ccc(cn1)C(=O)N2CCOCC2)C(=O)N(C=3)C)cccc(c4C)NC(=O)c5ccc(cc5)C(C)(C)C | InChi: | InChI=1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-12-26(13-10-23)34(2,3)4)25-19-29(33(42)38(5)21-25)36-30-14-11-24(20-35-30)32(41)39-15-17-43-18-16-39/h6-14,19-21H,15-18H2,1-5H3,(H,35,36)(H,37,40) | Definition date: | 2017-09-01 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | 4-tert-butyl-N-[2-methyl-3-(1-methyl-5-{[5-(morpholine-4-carbonyl)pyridin-2-yl]amino}-6-oxo-1,6-dihydropyridin-3-yl)phenyl]benzamide |
|
 | BZJ | Name: | 3-hydroxynaphthalene-2-carboxylic acid | Formula: | C11 H8 O3 | SMILES: | C(c1c(cc2c(c1)cccc2)O)(O)=O | InChi: | InChI=1S/C11H8O3/c12-10-6-8-4-2-1-3-7(8)5-9(10)11(13)14/h1-6,12H,(H,13,14) | Definition date: | 2017-09-06 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | 3-hydroxynaphthalene-2-carboxylic acid |
|
 | C0D | Name: | (2R)-2-hydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | Formula: | C14 H28 N2 O3 | SMILES: | CC(C(O)C(=O)NCCC(=O)NCCCCC)(C)C | InChi: | InChI=1S/C14H28N2O3/c1-5-6-7-9-15-11(17)8-10-16-13(19)12(18)14(2,3)4/h12,18H,5-10H2,1-4H3,(H,15,17)(H,16,19)/t12-/m0/s1 | Definition date: | 2017-09-06 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | (2R)-2-hydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide |
|
 | C0G | Name: | (2R)-N-(3-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}-3-oxopropyl)-2-hydroxy-3,3-dimethylbutanamide | Formula: | C17 H24 N2 O5 | SMILES: | CC(C(O)C(=O)NCCC(=O)NCc2cc1OCOc1cc2)(C)C | InChi: | InChI=1S/C17H24N2O5/c1-17(2,3)15(21)16(22)18-7-6-14(20)19-9-11-4-5-12-13(8-11)24-10-23-12/h4-5,8,15,21H,6-7,9-10H2,1-3H3,(H,18,22)(H,19,20)/t15-/m0/s1 | Definition date: | 2017-09-06 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | (2R)-N-(3-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}-3-oxopropyl)-2-hydroxy-3,3-dimethylbutanamide |
|
 | C0J | Name: | 2-fluoro-6-{[2-(pyridin-2-yl)ethyl]amino}benzonitrile | Formula: | C14 H12 F N3 | SMILES: | c2(C#N)c(NCCc1ccccn1)cccc2F | InChi: | InChI=1S/C14H12FN3/c15-13-5-3-6-14(12(13)10-16)18-9-7-11-4-1-2-8-17-11/h1-6,8,18H,7,9H2 | Definition date: | 2017-09-06 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | 2-fluoro-6-{[2-(pyridin-2-yl)ethyl]amino}benzonitrile |
|
 | C5V | Name: | (1S,2S)-N-{4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-(pyridin-3-yl)cyclopropane-1-carboxamide | Formula: | C24 H19 N3 O3 | SMILES: | C(c3ccc(NC(C1CC1c2cnccc2)=O)cc3)N4C(c5c(C4=O)cccc5)=O | InChi: | InChI=1S/C24H19N3O3/c28-22(21-12-20(21)16-4-3-11-25-13-16)26-17-9-7-15(8-10-17)14-27-23(29)18-5-1-2-6-19(18)24(27)30/h1-11,13,20-21H,12,14H2,(H,26,28)/t20-,21+/m1/s1 | Definition date: | 2017-09-13 | Last modified: | 2018-09-07 | Release date: | 2018-09-12 | Identifier: | (1S,2S)-N-{4-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-(pyridin-3-yl)cyclopropane-1-carboxamide |
|